Skip to content

Community Testing of Wearable Assistance

Community Testing of Wearable Assistance

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06244901
Enrollment
10
Registered
2024-02-06
Start date
2023-10-25
Completion date
2025-09-01
Last updated
2024-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

This feasibility study looks to evaluate ankle exoskeleton assistance in community settings for individuals with cerebral palsy.

Detailed description

Participants will undergo consent (if not done over the phone), history/physical/activity questionnaire, and orthotic device fitting. Following device fitting, the participants will practice walking with powered assistance. Next, participants will complete pre walking tests with and without the device (order randomized) on a 15-minute pre planned community walk in close proximity with their own home. Distance, time, heart-rate, and perceived exertion will be recorded. The expected duration is 1-2 hours. Next, participants will be asked to complete (under parental supervision for minors) the pre-determined walking route every day for 1 week with or without ankle exoskeleton assistance (block randomized). Following the first week of independent walking practice, participants will complete post walking tests with and without the device on the same walking route. Distance, time, heart-rate, and perceived exertion will be recorded. The expected duration is 1-2 hours. Participants will then have a 2-6 week washout period. Following this washout, the pre- and post-assessments will be completed before and after, respectively, another week of identical community walking practice completed under the remaining condition (either exoskeleton or no exoskeleton).

Interventions

Walking for twenty minutes with a wearable powered robotic ankle exoskeleton on real-world terrain every day for a week.

Normal walking for twenty minutes on real-world terrain every day for a week.

Sponsors

Northern Arizona University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cerebral palsy * Gross Motor Function Classification Level I, II, or III * Able to walk for at least 20 minutes with or without a walking aid * Able to safely fit into a device configuration and tolerate assistance without knee hyperextension while walking * Able to provide verbal assent, if appropriate. If the participant is non-verbal, parental interpretation of gesticulation for assent will be used.

Exclusion criteria

* Any neurological, musculoskeletal or cardiorespiratory injury, health condition ( including pregnancy), or diagnosis other than cerebral palsy that would affect the ability to walk as directed for short periods of time. * Participant or parent report that the perspective participant's physician has recommended that they not engage in moderate intensity walking exercise.

Design outcomes

Primary

MeasureTime frameDescription
Walking speedthrough study completion, an average of one weekChange in walking speed (measured in meters per second)

Secondary

MeasureTime frameDescription
Step lengthThrough study completion, an average of one weekChange in step length (measured in meters)
Heart-rateThrough study completion, an average of one weekChange in heart rate (measured in beats per minute)
Perceived exertionThrough study completion, an average of one weekChange in perceived exertion (measured on a 1-10 scale)

Countries

United States

Contacts

Primary ContactZach Lerner, PhD
Zachary.Lerner@nau.edu928-523-1787

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026